Ensign Peak Advisors, Inc Edwards Lifesciences Corp Transaction History

Ensign Peak Advisors, Inc

$56.1 Billion
Q3 2024

A detailed history of Ensign Peak Advisors, Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 222,686 shares of EW stock, worth $16.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

222,686

Previous 239,886 7.17%

Holding current value

$16.5 Million

Previous $22.2 Million 33.68%

% of portfolio

0.03%

Previous 0.04%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$59.7 - $93.78 $1.03 Million - $1.61 Million	-17,200 Reduced 7.17%	222,686 $14.7 Million
Q2 2024 Aug 13, 2024	SELL	$84.3 - $94.31 $2.16 Million - $2.41 Million	-25,590 Reduced 9.64%	239,886 $22.2 Million
Q1 2024 May 14, 2024	BUY	$72.54 - $95.56 $286,460 - $377,366	3,949 Added 1.51%	265,476 $25.4 Million
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $1.8 Million - $2.27 Million	29,234 Added 12.58%	261,527 $19.9 Million
Q3 2023 Nov 13, 2023	SELL	$69.28 - $93.38 $635,366 - $856,387	-9,171 Reduced 3.8%	232,293 $16.1 Million
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $863,760 - $1 Million	10,610 Added 4.6%	241,464 $22.8 Million
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $6.93 Million - $7.89 Million	-93,366 Reduced 28.8%	230,854 $19.1 Million
Q4 2022 Feb 13, 2023	BUY	$68.3 - $87.44 $17.6 Million - $22.6 Million	258,313 Added 391.94%	324,220 $24.2 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $287,059 - $373,905	-3,485 Reduced 5.02%	65,907 $5.45 Million
Q2 2022 Aug 12, 2022	SELL	$86.5 - $128.27 $296,695 - $439,966	-3,430 Reduced 4.71%	69,392 $6.6 Million
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $11.2 Million - $14.1 Million	-110,205 Reduced 60.21%	72,822 $8.57 Million
Q4 2021 Feb 11, 2022	BUY	$106.37 - $130.68 $12.4 Million - $15.2 Million	116,418 Added 174.78%	183,027 $23.7 Million
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $11,731 - $13,993	114 Added 0.17%	66,609 $7.54 Million
Q2 2021 Aug 13, 2021	SELL	$83.84 - $104.76 $718,508 - $897,793	-8,570 Reduced 11.42%	66,495 $6.89 Million
Q1 2021 May 12, 2021	SELL	$78.68 - $90.67 $1.83 Million - $2.11 Million	-23,315 Reduced 23.7%	75,065 $6.28 Million
Q4 2020 Feb 12, 2021	SELL	$71.69 - $91.23 $16.1 Million - $20.5 Million	-224,565 Reduced 69.54%	98,380 $8.98 Million
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $5.56 Million - $7.23 Million	82,730 Added 34.44%	322,945 $25.8 Million
Q2 2020 Aug 12, 2020	BUY	$57.54 - $76.95 $11 Million - $14.7 Million	191,272 Added 390.81%	240,215 $16.6 Million
Q1 2020 May 11, 2020	SELL	$52.41 - $81.0 $1.44 Million - $2.22 Million	-27,410 Reduced 35.9%	48,943 $9.23 Million
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $5.47 Million - $6.27 Million	76,353 New	76,353 $17.8 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

456M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Edwards Lifesciences Corp Transaction History